DOMPE
Nicola Detta has extensive experience in the field of molecular biology and protein formulation. Currently serving as Proteins Formulation Manager at Dompé, previous roles include Proteins Formulation Senior Specialist and Molecular Biologist - Biotech Protein Formulation Scientist. At IRCCS Istituto Nazionale Tumori Fondazione G Pascale in Napoli, Italy, Nicola focused on somatic mutations' role in resistance to anti-EGFR drugs in plasmatic tumor DNA. Additional experience includes post-doctoral research at CEINGE Biotecnologie Avanzate, where Nicola conducted functional studies in ion channels involved in inherited diseases, as well as managing biomedical research projects. Nicola holds a PhD in Genetics and Molecular Medicine from the University of Naples, obtained from 2007 to 2011, and has completed specialist training in biotech protein/peptide formulation through PharmaTraining in 2019.
DOMPE
2 followers
DOMPE is a biopharmaceutical company that is committed to research and development to meet unsatisfied therapeutic needs. The company's products are engaged in the development and distribution of ethical drugs and self-medication, adjuvants, medical devices and cosmetics, and in the fields of vitamin and mineral supplements and personalhygiene. The therapeutic areas include cardiovascular, gastrointestinal, pediatrics, neurology, urology, ophthalmic, stomatology, and respiratory.Founded in 1940, Dompe is headquartered in Milan, Italy.